Abstract
BackgroundTherapeutic approaches utilizing IL2 or IL15 have suffered from low tolerability, fast clearance, and limited therapeutic window due to extensive activity on peripheral T and NK cells. Conversely, selective targeting...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
